 Home > Active Ingredient News > Infection > GSK antibody drug otilimab for the treatment of COVID-19 has shown potential in elderly patients!

GSK antibody drug otilimab for the treatment of COVID-19 has shown potential in elderly patients!

 Last Update: 2021-03-20
 Source: Internet
 Author: User

Tags

astrocytoma survival rate

new hope marine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

GlaxoSmithKline (GSK) today reported the Phase II clinical data of the research antibody otilimab in COVID-19 hospitalized patients.

COVID-19

The primary endpoint of the OSCAR Phase II study is the 28-day survival rate after receiving a single dose of otilimab in combination with standard treatment.

Although the results for patients of all ages are disappointing, the efficacy analysis for patients 70 years and older shows that 28 days after otilimab treatment, 65.

Most importantly, the mortality analysis on the 60th day showed that the mortality rate in the standard treatment group was 40%, while the mortality rate in the otilimab treatment group was 26%.

Original source:

http:// href="http://" target="_blank" rel="noopener">http:// style="vertical-align: inherit;"> http:// Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Phenol CAS NO. 108-95-2 Factory Supply 99% High Quality liquid

CAS No.: 108-95-2

Industrial Grade

$1-1.2/KG FOB

High Quality Trichloroisocyanuric acid 90% powder tabella particle 87-90-1 -Shaanxi Dideu Medichem Co.Ltd

CAS No.: 87-90-1

Chemical Grade

$1/KG FOB

OXITETRACICLINA BASE

CAS No.: 6153-64-6

Industrial Grade

$1-1.02/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.